Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
End stage kidney disease
How can narrative medicine be used to potentially improve outcomes for patients on dialysis?
Related Questions
What is your preferred method for latent tuberculosis screening prior to outpatient hemodialysis initiation for a patient with new dialysis requirements?
Would you use IV albumin before hemodialysis for hypotension if the serum albumin is greater than 3.5 g/dl?
Do you recommend first consulting interventional radiology or vascular surgery if you lack access to interventional nephrology in a patient with ESKD who is suspected of having a clotted fistula and is unable to receive hemodialysis?
Do you use the same hemoglobin target as an ESKD patient for an outpatient with AKI-D who has been receiving dialysis for more than 30 days and is prescribed an ESA?
How do you work up and manage an ESKD patient with controlled blood pressure who complains of recurrent headaches while on hemodialysis?
Do you recommend avoiding ESAs in ESKD patients with heart failure who require a left ventricular assist device?
What is your approach to intensifying the hemodialysis prescription for patients found to have dialysis-related amyloidosis?
Are you comfortable using low molecular weight heparin as an alternative to unfractionated heparin for ESKD patients on nocturnal home hemodialysis?
Do you dose ESAs via an intravenous or subcutaneous route for hospitalized patients with ESKD and anemia?
Do you take any special considerations for a patient with ESKD who has an ileostomy/colostomy and wishes to start peritoneal dialysis?
